Inpatient safety, effectiveness of SGLT2 inhibitors and GLP-1 RAs in type 2 diabetes: ENDOCARE, a pragmatic prospective cohort study.
Saved in:
| Title: | Inpatient safety, effectiveness of SGLT2 inhibitors and GLP-1 RAs in type 2 diabetes: ENDOCARE, a pragmatic prospective cohort study. |
|---|---|
| Authors: | Moreno-Pérez Ó; Department of Endocrinology and Nutrition, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, C/ Pintor Baeza S/N. CP 03010, Alicante, Spain. omorenoperez@hotmail.es.; Department of Clinical Medicine, Miguel Hernández University, Elche, Spain. omorenoperez@hotmail.es., Tejera-Muñoz A; Department of Endocrinology and Nutrition, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, C/ Pintor Baeza S/N. CP 03010, Alicante, Spain.; University Centre for Health Sciences - HM Hospitals (CUHMED), Camilo Jose Cela University, Madrid, Spain., Leiva-Mora N; Department of Endocrinology and Nutrition, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, C/ Pintor Baeza S/N. CP 03010, Alicante, Spain., Santacruz E; Department of Endocrinology and Nutrition, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, C/ Pintor Baeza S/N. CP 03010, Alicante, Spain., Sánchez-Ortiga R; Department of Endocrinology and Nutrition, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, C/ Pintor Baeza S/N. CP 03010, Alicante, Spain., Arrarte V; Department of Clinical Medicine, Miguel Hernández University, Elche, Spain.; Department of Cardiology, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, Alicante, Spain., Climent-Grana E; Department of Pharmacy, General University Hospital Dr. Balmis of Alicante. Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, Alicante, Spain., Sandin M; Department of Cardiology, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, Alicante, Spain., Riera G; Department of Pharmacy, General University Hospital Dr. Balmis of Alicante. Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, Alicante, Spain., Lopez-Mondejar P; Department of Endocrinology and Nutrition, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, C/ Pintor Baeza S/N. CP 03010, Alicante, Spain., López-Muñoz B; Department of Endocrinology and Nutrition, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, C/ Pintor Baeza S/N. CP 03010, Alicante, Spain., Navarro C; Department of Endocrinology and Nutrition, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, C/ Pintor Baeza S/N. CP 03010, Alicante, Spain., Guillen-Morote C; Department of Endocrinology and Nutrition, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, C/ Pintor Baeza S/N. CP 03010, Alicante, Spain., Roldán-Sánchez A; Department of Endocrinology and Nutrition, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, C/ Pintor Baeza S/N. CP 03010, Alicante, Spain., Sánchez-Pacheco M; Department of Endocrinology and Nutrition, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, C/ Pintor Baeza S/N. CP 03010, Alicante, Spain., Abad-González ÁL; Department of Endocrinology and Nutrition, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, C/ Pintor Baeza S/N. CP 03010, Alicante, Spain., Llorens P; Emergency Department, Short Stay Unit and Hospitalization at Home Unit, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, Alicante, Spain.; Medicine Area, University of Alicante, Alicante, Spain., Pico-Alfonso A; Department of Endocrinology and Nutrition, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, C/ Pintor Baeza S/N. CP 03010, Alicante, Spain.; Department of Clinical Medicine, Miguel Hernández University, Elche, Spain.; Center for Biomedical Research On Rare Diseases (CIBER-ER), Instituto de Salud Carlos III, Madrid, Spain., Serrano-Gotarredona J; Department of Endocrinology and Nutrition, General University Hospital Dr. Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, C/ Pintor Baeza S/N. CP 03010, Alicante, Spain.; Department of Clinical Medicine, Miguel Hernández University, Elche, Spain. |
| Source: | Cardiovascular diabetology [Cardiovasc Diabetol] 2026 Mar 30; Vol. 25 (1). Date of Electronic Publication: 2026 Mar 30. |
| Publication Type: | Journal Article; Pragmatic Clinical Trial |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
